StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.99−0.25 (-4.77%)

Close on Nov 17, 2026Market cap $489.46MP/E –Yield –

aTYR PHARMA profit margin

Profit margin (net margin) is net income as a percentage of revenue.

aTYR PHARMA's profit margin for the twelve months ending Dec 31, 2025 was -39009.5%. For fiscal 2025 it was -39009.5%, against -27243.8% the year before. The highest annual figure on record is -155.2% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-39009.5%−11765.6
FY2024Dec 31, 2024-27243.8%−12969.3
FY2023Dec 31, 2023-14274.5%−13838.0
FY2022Dec 31, 2022-436.5%−281.4
FY2020Dec 31, 2020-155.2%+3689.4
FY2019Dec 31, 2019-3844.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 2025-13549.5%−13309.2
Q1 FY2024Mar 31, 2024-6591.9%−2133.1
Q3 FY2023Sep 30, 2023-3212.5%+198.1
Q4 FY2022Dec 31, 2022-72.4%−94.2
Q4 FY2020Dec 31, 2020-240.2%+3907.7
Q3 FY2020Sep 30, 2020-4458.8%−1390.8
Q2 FY2020Jun 30, 2020-3410.6%+2810.7
Q1 FY2020Mar 31, 202021.7%–
Q4 FY2019Dec 31, 2019-4147.9%–
Q3 FY2019Sep 30, 2019-3067.9%–
Q2 FY2019Jun 30, 2019-6221.3%–

More aTYR PHARMA figures

See a number that looks wrong?